Carladenise Armbrister Edwards, Ph.D.
Board Member
Clover Health Investments, Corp. /De (CLOV)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carladenise Armbrister Edwards, Ph.D.
Carladenise Armbrister Edwards, Ph.D. is recorded as Board Member at Clover Health Investments, Corp. /De (CLOV). Clover Health Investments, Corp. /De reported in an 8-K filed July 26, 2022 that Carladenise Armbrister Edwards, Ph.D. was appointed Class III director of the Board and as a member of the Talent and Compensation Committee and the Nominating and Corporate Govern, effective July 22, 2022.
“On July 22, 2022, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Carladenise Armbrister Edwards, Ph.D., Executive Vice President and Chief Strategy Officer of the Henry Ford Health System, to serve as a Class III director of the Board and as a member of the Talent and Compensation Committee and the Nominating and Corporate Governance Committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-07-22–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Clover Health Investments, Corp. /De
Other people whose current roles at this company are on record from its filings.
- Andrew Toy CEO, Board Member
- Conrad Wai CEO, CTO
- Jamie L. Reynoso CEO, COO
- Vivek Garipalli Chairman, Board Member
- Clay Thornton CFO
- Joseph Wagner CFO
- Gia Lee General Counsel
- Karen Soares General Counsel
- Joseph (Joe) Oldakowski Chief Accounting Officer
- Mark Herbers Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.